Trial Profile
A Single Dose, Randomized, Open-label, 2x2 Crossover Study to Evaluate the Bioavailability and Safety of AGSAV301 Tablet in Healthy Male Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Levamlodipine/valsartan (Primary) ; Amlodipine/valsartan
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Ahn-Gook Pharmaceutical
- 01 Mar 2012 New trial record